Profile
Elliot J.
Favus founded Favus Institutional Research LLC in 2009, where he is working as Chief Executive Officer from 2009.
Dr. Favus also currently works at Xequel Bio, Inc., as Director.
Dr. Favus also formerly worked at Anavex Life Sciences Corp., as Independent Director from 2014 to 2021, Sculptor Capital LP, as Analyst, and FM Partners Holdings LLC, as Research Associate.
Dr. Favus received his undergraduate degree in 1996 from the University of Michigan and doctorate degree in 2001 from Pritzker School of Medicine.
Elliot J. Favus active positions
| Companies | Position | Start |
|---|---|---|
Favus Institutional Research LLC
Favus Institutional Research LLC Investment ManagersFinance Provides investment research | Chief Executive Officer | 01/01/2009 |
Xequel Bio, Inc.
Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration | Director/Board Member | - |
Former positions of Elliot J. Favus
| Companies | Position | End |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Director/Board Member | 26/05/2021 |
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 30/12/2007 |
Sculptor Capital LP
Sculptor Capital LP Investment ManagersFinance Sculptor Capital seeks to generate attractive risk-adjusted returns across market cycles and provides a range of products across multi-strategies, credit, and real estate. The firm conducts due diligence based on the facts and circumstances applicable to each investment and evaluates potential investments. | Analyst-Equity | - |
Training of Elliot J. Favus
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Sculptor Capital LP
Sculptor Capital LP Investment ManagersFinance Sculptor Capital seeks to generate attractive risk-adjusted returns across market cycles and provides a range of products across multi-strategies, credit, and real estate. The firm conducts due diligence based on the facts and circumstances applicable to each investment and evaluates potential investments. | Finance |
Xequel Bio, Inc.
Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration | Health Technology |
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Favus Institutional Research LLC
Favus Institutional Research LLC Investment ManagersFinance Provides investment research | Finance |
Pritzker School of Medicine
Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Elliot J. Favus
















